Chemotherapy for solid tumoursBMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6990.1328c (Published 20 May 1995) Cite this as: BMJ 1995;310:1328
- A G Dalgleish
- Professor of oncology Division of Oncology, Department of Cellular and Molecular Sciences, St George's Hospital Medical School, London SW17 0RE
EDITOR,—It is easy to sympathise with some of the points on both sides of the argument over whether chemotherapy should be given for solid tumours.1 The nihilistic approach promulgated by G M Mead, however, would lead to no advances in treatment being made. As Mead points out, treatments that might benefit only a small percentage of patients will be sought by most patients—though not by their doctors, as pointed out by Slevin et al.2 The dramatic improvement in …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial